Initializing...

Our Virtual Facilitator is here to help you navigate your research process by answering questions, directing you to resources, and connecting you to Facilitators. Check out our Guides & Tools page for examples of what it can do.

By using this chatbot you are agreeing to HIPAA guidelines and agree not to enter any sensitive information - Protected Health Information (PHI), Personal Information (PI), and/or Intellectual Property (IP) in the chat.

This conversation is about to expire due to inactivity.

Click “Continue” to extend your conversation and continue chatting.

This conversation has expired due to inactivity.

Refresh this page to start a new conversation.

<< BACK TO PLAYBOOK

Investigational New Drug (IND) and Investigational Device Exemption (IDE)

Investigational New Drug (IND) and Investigational Device Exemption (IDE)

The Education and Compliance Support for Human Subjects Research ECS-HSR Office at the University of Pittsburgh provides information for Investigator-Sponsors and study teams if an IND or an IDE is needed. Not every study involving a drug or device must be conducted under an IND/IDE application.

Please read ECS-HSR Guidance and email the ECS-HSR Office below, if you have any questions.

If you determine that an IND/IDE is needed, the office will assist in preparing, submitting, and maintaining applications to the Food and Drug Administration (FDA) for FDA regulated clinical trials. FDA and IRB approved studies may be provided with monitoring services from an Education and Compliance Support Coordinator to assist with your study and execute sponsor requirements.

ECS-HSR IND, IDE Support

FDA IDE Approval Process

Contact(s):

ECS-HSR Office

  • Study Development, Planning, and Design
  • Study Start-Up
  • Study Conduct
  • Study Close-Out
  • Regulatory and Compliance
You have temporarily dismissed this card.